FDA Authorizes Pharmacists to Prescribe Paxlovid
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
The FDA has granted state-licensed pharmacists the power to prescribe Paxlovid (nirmatrelvir and ritonavir) to eligible patients, with certain limitations.
The COVID vaccine is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a study of 229,235 CVD patients.
People with food allergies are less likely to become infected with COVID, while obesity and BMI are tied to increased risk for SARS-CoV-2 infection. In addition, researchers say asthma does not increase risk for COVID.
The FDA unveiled an ALS Action Plan for Rare Neurodegenerative Diseases, a five-year strategy for improving and extending the lives of people living with rare neurodegenerative diseases.
UT Southwestern researchers identified a new function for a protein called TAO2 that appears to be key to inhibiting flu replication, according to a study published in PNAS.
A novel treatment for opioid-induced respiratory depression that administers electrical pulses to the back of the neck helped anesthetized patients undergoing neurosurgery regain respiratory control following high dosage opioid use.
Research published in JAMA Network Open shows an increase in the proportion of African American patients screened in the first nine months after the USPTF 2021 Lung Cancer Screening Guidelines took effect.
At SLEEP 2022, SleepRes LLC introduced the V-Com, a CPAP accessory that the company...